XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Conversa Health Inc. [Member]
Silver Cloud Health Holdings, Inc. [Member]
Common Stock [Member]
Common Stock [Member]
Conversa Health Inc. [Member]
Common Stock [Member]
Silver Cloud Health Holdings, Inc. [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Conversa Health Inc. [Member]
Additional Paid-in Capital [Member]
Silver Cloud Health Holdings, Inc. [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Equity (Deficit) [Member]
American Well Corporation Stockholder Equity (Deficit) [Member]
American Well Corporation Stockholder Equity (Deficit) [Member]
Conversa Health Inc. [Member]
American Well Corporation Stockholder Equity (Deficit) [Member]
Silver Cloud Health Holdings, Inc. [Member]
Noncontrolling Interest [Member]
Beginning balance at Dec. 31, 2021 $ 1,260,875     $ 2,620     $ 2,054,275     $ (6,353) $ (811,284) $ 1,239,258     $ 21,617
Beginning balance (in shares) at Dec. 31, 2021       261,871,587                      
Exercise of common stock options 2,465     $ 10     2,455         2,465      
Exercise of common stock options, Shares       976,644                      
Vesting of restricted stock units       $ 14     (14)                
Vesting of restricted stock units, Shares       1,398,305                      
Issuance of stock under employee stock purchase plan 1,501     $ 4     1,497         1,501      
Issuance of stock under employee stock purchase plan,Shares       425,114                      
Issuance of common stock related to Conversa/SilverCloud earn-out settlement   $ 4,298     $ 10     $ 4,288         $ 4,298    
Issuance of common stock related to Conversa/SilverCloud earn-out settlement, Shares         1,020,964                    
Stock-based compensation expense 12,085           12,085         12,085      
Capital contributed by selling shareholders of acquired businesses 2,019           2,019         2,019      
Currency translation adjustment (2,951)                 (2,951)   (2,951)      
Unrealized gains (losses) on available-for-sale securities, net of tax (1,251)                 (1,251)   (1,251)      
Net loss (70,253)                   (70,037) (70,037)     (216)
Ending balance at Mar. 31, 2022 1,208,788     $ 2,658     2,076,605     (10,555) (881,321) 1,187,387     21,401
Ending balance, Shares at Mar. 31, 2022       265,692,614                      
Beginning balance at Dec. 31, 2021 1,260,875     $ 2,620     2,054,275     (6,353) (811,284) 1,239,258     21,617
Beginning balance (in shares) at Dec. 31, 2021       261,871,587                      
Currency translation adjustment (24,343)                            
Unrealized gains (losses) on available-for-sale securities, net of tax (360)                            
Net loss (210,480)                            
Ending balance at Sep. 30, 2022 1,104,849     $ 2,753     2,133,614     (31,056) (1,020,865) 1,084,446     20,403
Ending balance, Shares at Sep. 30, 2022       275,250,318                      
Beginning balance at Mar. 31, 2022 1,208,788     $ 2,658     2,076,605     (10,555) (881,321) 1,187,387     21,401
Beginning balance (in shares) at Mar. 31, 2022       265,692,614                      
Exercise of common stock options 1,926     $ 10     1,916         1,926      
Exercise of common stock options, Shares       1,083,571                      
Vesting of restricted stock units       $ 16     (16)                
Vesting of restricted stock units, Shares       1,606,976                      
Issuance of common stock related to Conversa/SilverCloud earn-out settlement     $ 12,945     $ 50     $ 12,895         $ 12,945  
Issuance of common stock related to Conversa/SilverCloud earn-out settlement, Shares           4,959,856                  
Receipt of Section 16(b) disgorgement 295           295         295      
Stock-based compensation expense 14,907           14,907         14,907      
Capital contributed by selling shareholders of acquired businesses 1,974           1,974         1,974      
Currency translation adjustment (10,179)                 (10,179)   (10,179)      
Unrealized gains (losses) on available-for-sale securities, net of tax (111)                 (111)   (111)      
Net loss (69,652)                   (69,145) (69,145)     (507)
Ending balance at Jun. 30, 2022 1,160,893     $ 2,734     2,108,576     (20,845) (950,466) 1,139,999     20,894
Ending balance, Shares at Jun. 30, 2022       273,343,017                      
Exercise of common stock options 858     $ 5     853         858      
Exercise of common stock options, Shares       464,622                      
Vesting of restricted stock units       $ 12     (12)                
Vesting of restricted stock units, Shares       1,249,647                      
Shares withheld related to net share settlement and retired treasury stock in 2022 (360)     $ (1)     (44)       (315) (360)      
Shares withheld related to net share settlement and retired treasury stock, Shares       (85,002)                      
Issuance of stock under employee stock purchase plan 1,002     $ 3     999         1,002      
Issuance of stock under employee stock purchase plan,Shares       278,034                      
Stock-based compensation expense 21,312           21,312         21,312      
Capital contributed by selling shareholders of acquired businesses 1,930           1,930         1,930      
Currency translation adjustment (11,213)                 (11,213)   (11,213)      
Unrealized gains (losses) on available-for-sale securities, net of tax 1,002                 1,002   1,002      
Net loss (70,575)                   (70,084) (70,084)     (491)
Ending balance at Sep. 30, 2022 1,104,849     $ 2,753     2,133,614     (31,056) (1,020,865) 1,084,446     20,403
Ending balance, Shares at Sep. 30, 2022       275,250,318                      
Beginning balance at Dec. 31, 2022 1,083,851     $ 2,766     2,160,108     (16,969) (1,082,028) 1,063,877     19,974
Beginning balance (in shares) at Dec. 31, 2022       277,139,679                      
Exercise of common stock options 289     $ 1     288         289      
Exercise of common stock options, Shares       128,572                      
Vesting of restricted stock units       $ 29     (29)                
Vesting of restricted stock units, Shares       2,927,471                      
Shares repurchased and retired (1)                   (1) (1)      
Shares repurchased and retired,Shares       (316)                      
Issuance of stock under employee stock purchase plan 1,268     $ 5     1,263         1,268      
Issuance of stock under employee stock purchase plan,Shares       513,339                      
Stock-based compensation expense 20,997           20,997         20,997      
Currency translation adjustment 2,062                 2,062   2,062      
Unrealized gains (losses) on available-for-sale securities, net of tax 4,319                 4,319   4,319      
Net loss (398,509)                   (397,688) (397,688)     (821)
Ending balance at Mar. 31, 2023 714,276     $ 2,801     2,182,627     (10,588) (1,479,717) 695,123     19,153
Ending balance, Shares at Mar. 31, 2023       280,708,745                      
Beginning balance at Dec. 31, 2022 1,083,851     $ 2,766     2,160,108     (16,969) (1,082,028) 1,063,877     19,974
Beginning balance (in shares) at Dec. 31, 2022       277,139,679                      
Currency translation adjustment 355                            
Unrealized gains (losses) on available-for-sale securities, net of tax 3,062                            
Net loss (629,128)                            
Ending balance at Sep. 30, 2023 519,696     $ 2,864     2,222,152     (13,552) (1,709,191) 502,273     17,423
Ending balance, Shares at Sep. 30, 2023       286,984,129                      
Beginning balance at Mar. 31, 2023 714,276     $ 2,801     2,182,627     (10,588) (1,479,717) 695,123     19,153
Beginning balance (in shares) at Mar. 31, 2023       280,708,745                      
Exercise of common stock options 280     $ 2     278         280      
Exercise of common stock options, Shares       158,027                      
Vesting of restricted stock units       $ 34     (34)                
Vesting of restricted stock units, Shares       3,420,846                      
Shares repurchased and retired (585)     $ (3)     3       (585) (585)      
Shares repurchased and retired,Shares       (264,671)                      
Stock-based compensation expense 21,513           21,513         21,513      
Currency translation adjustment (214)                 (214)   (214)      
Unrealized gains (losses) on available-for-sale securities, net of tax 1,933                 1,933   1,933      
Net loss (93,515)                   (92,475) (92,475)     (1,040)
Ending balance at Jun. 30, 2023 643,688     $ 2,834     2,204,387     (8,869) (1,572,777) 625,575     18,113
Ending balance, Shares at Jun. 30, 2023       284,022,947                      
Vesting of restricted stock units       $ 23     (23)                
Vesting of restricted stock units, Shares       2,250,209                      
Issuance of stock under employee stock purchase plan 896     $ 7     889         896      
Issuance of stock under employee stock purchase plan,Shares       710,973                      
Stock-based compensation expense 16,899           1,689         16,899      
Currency translation adjustment (1,493)                 (1,493)   (1,493)      
Unrealized gains (losses) on available-for-sale securities, net of tax (3,190)                 (3,190)   (3,190)      
Net loss (137,104)                   (136,414) (136,414)     (690)
Ending balance at Sep. 30, 2023 $ 519,696     $ 2,864     $ 2,222,152     $ (13,552) $ (1,709,191) $ 502,273     $ 17,423
Ending balance, Shares at Sep. 30, 2023       286,984,129